Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Comparative Study of Concurrent Intraprostatic Botulinum Toxin-A Injection During Endoscopic Prostate Surgery Versus Postoperative Medical Therapy in BPH Patients With Overactive Bladder Symptoms

NCT07554989 is registered in ClinicalTrials.gov with Taksim Egitim ve Arastirma Hastanesi as lead sponsor.

NCT NCT07554989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07554989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Comparative Study of Concurrent Intraprostatic Botulinum Toxin-A Injection During Endoscopic Prostate Surgery Versus Postoperative Medical Therapy in BPH Patients With Overactive Bladder Symptoms
Lead sponsor
Taksim Egitim ve Arastirma Hastanesi
Phase
Observational
Overall status
Active, not recruiting
Start date
April 1, 2026
Completion date
April 1, 2027
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder outlet obstruction, botulinium toxin-a, prostatic hyperplasia, benign, urinary bladder, overactive